You seem to be using a wider screen, would you like to enable a wider viewing experience on this page?
Remedy Q4’25: The stakes are high
Remedy's investment story is entering a pivotal year, as the company is about to release what is arguably its most important game so far: Control Resonant. For the value creation of Remedy's share, it is essential to succeed with the release. Analyst Atte Riikola summarizes.